Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activity
about
Current understanding of interactions between nanoparticles and the immune systemCritical questions in development of targeted nanoparticle therapeuticsImmunosuppressive and anti-inflammatory properties of engineered nanomaterialsPre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategyDegradable Polyethylenimine-Based Gene Carriers for Cancer Therapy.Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.
P2860
Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activity
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inhibition of phosphoinositol ...... eukocyte procoagulant activity
@ast
Inhibition of phosphoinositol ...... eukocyte procoagulant activity
@en
Inhibition of phosphoinositol ...... eukocyte procoagulant activity
@nl
type
label
Inhibition of phosphoinositol ...... eukocyte procoagulant activity
@ast
Inhibition of phosphoinositol ...... eukocyte procoagulant activity
@en
Inhibition of phosphoinositol ...... eukocyte procoagulant activity
@nl
prefLabel
Inhibition of phosphoinositol ...... eukocyte procoagulant activity
@ast
Inhibition of phosphoinositol ...... eukocyte procoagulant activity
@en
Inhibition of phosphoinositol ...... eukocyte procoagulant activity
@nl
P2093
P2860
P3181
P356
P1433
P1476
Inhibition of phosphoinositol ...... eukocyte procoagulant activity
@en
P2093
Anil K Patri
Anna N Ilinskaya
Marina A Dobrovolskaia
Rachael M Crist
Raul E Cachau
Scott E McNeil
P2860
P304
P3181
P356
10.2217/NNM.13.137
P407
P577
2013-11-27T00:00:00Z